Increased biologically effective dose (BED) to the primary tumor improves survival in patients with oligometastatic NSCLC: A retrospective dose response analysis Meeting Abstract


Authors: Farooqi, A.; Ludmir, E. B.; Mitchell, K. G.; Antonoff, M.; Gomez, D. R.; Gandhi, S.
Abstract Title: Increased biologically effective dose (BED) to the primary tumor improves survival in patients with oligometastatic NSCLC: A retrospective dose response analysis
Meeting Title: 2019 ASTRO Research Workshop on Treatment of Oligometastatic Disease
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 104
Issue: 5
Meeting Dates: 2019 Jun 13-14
Meeting Location: Washington, DC
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2019-08-01
Start Page: 1192
End Page: 1193
Language: English
ACCESSION: WOS:000475856100056
DOI: 10.1016/j.ijrobp.2019.05.051
PROVIDER: Clarivate Analytics Web of Science
PROVIDER: wos
Notes: Meeting Abstract: 9 -- Source: Wos
Altmetric Score
MSK Authors
  1. Daniel R Gomez
    23 Gomez